Carmen Cuffari
Overview
Explore the profile of Carmen Cuffari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Flood E, Silberg D, Romero B, Beusterien K, Erder M, Cuffari C
BMC Res Notes
. 2017 Sep;
10(1):491.
PMID: 28946891
Background: The purpose of this study is to develop patient-reported (PRO) and observer-reported (ObsRO) outcome measures of ulcerative colitis (UC) signs/symptoms in children aged 5-17 with mild/moderate UC. The daily...
12.
Cuffari C
Gastroenterol Hepatol (N Y)
. 2017 Feb;
2(1):58-63.
PMID: 28210198
6-Mercaptopurine (6-MP) and its prodrug azathioprine (AZA) have proven efficacy in the maintenance of disease remission in patients with inflammatory bowel disease. Inherent differences in drug metabolism based on genetic...
13.
Cuffari C, Pierce D, Korczowski B, Fyderek K, Van Heusen H, Hossack S, et al.
Drug Des Devel Ther
. 2016 Feb;
10:593-607.
PMID: 26893546
Background: Limited data are available on mesalamine (5-aminosalicylic acid; 5-ASA) use in pediatric ulcerative colitis (UC). Aim: To evaluate pharmacokinetic and safety profiles of 5-ASA and metabolite acetyl-5-ASA (Ac-5-ASA) after...
14.
Vasilescu A, Cuffari C, Santo Domingo L, Scheimann A
Pancreas
. 2014 Dec;
44(3):401-3.
PMID: 25469545
Objective: Acute pancreatitis is one of the leading causes of rising pediatric hospitalizations in North America. The aim of this study was to assess the role of nutritional status and...
15.
Walia R, Garg S, Song Y, Girotra M, Cuffari C, Fricke W, et al.
J Pediatr Gastroenterol Nutr
. 2014 Jul;
59(5):565-70.
PMID: 25023578
Fecal microbiota transplantation (FMT) is recognized as an alternative therapeutic modality for recurrent Clostridium difficile infection (RCDI); however, data on its efficacy in children are lacking, including its effect on...
16.
Wang M, Okazaki T, Kugathasan S, Cho J, Isaacs K, Lewis J, et al.
Inflamm Bowel Dis
. 2012 Mar;
18(12):2277-87.
PMID: 22411504
Background: African Americans (AAs) are an admixed population of West African (WA) and European ancestry (EA). Crohn's disease (CD) susceptibility genes have not been established. We therefore evaluated the contribution...
17.
Conklin L, Cuffari C, Okazaki T, Miao Y, Saatian B, Chen T, et al.
J Dig Dis
. 2012 Jan;
13(2):82-93.
PMID: 22257476
Objective: 6-mercaptopurine (6-MP) is efficacious in the treatment of inflammatory bowel disease (IBD). However, about one-third of patients respond poorly to therapy. This study aimed to characterize the inherent differences...
18.
Chirumamilla S, He C, Racusen L, Scheimann A, Cuffari C
World J Pediatr
. 2011 Aug;
9(1):84-6.
PMID: 21874614
Background: Mesalamine or 5-aminosalicylic acid (5-ASA) has proven efficacy in treating patients with ulcerative colitis (UC). Although mesalamine is considered safe, it has been associated with acute interstitial nephritis and...
19.
Parashette K, Makam R, Cuffari C
Clin Exp Gastroenterol
. 2011 Jun;
3:57-63.
PMID: 21694847
Anti-tumor necrosis factor alpha (TNF-α) therapy has re-defined our treatment paradigms in managing patients with Crohn's disease (CD) and ulcerative colitis. Although the ACCENT studies showed proven efficacy in the...
20.
Fortunato J, Cuffari C
Curr Gastroenterol Rep
. 2011 Mar;
13(3):293-9.
PMID: 21409518
Percutaneous endoscopic gastrostomy (PEG) is a relatively safe and minimally invasive surgical method for providing enteral access in children. In pediatrics, the indications for PEG placement frequently include malnutrition or...